Ravulizumab Recruiting Phase 3 Trials for CKD / Cardiopulmonary Bypass / Cardiac Diseases / Chronic Kidney Disease (CKD) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT05746559ARTEMIS: Ravulizumab to Protect Patients With CKD From CSA-AKI and MAKE